These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 36086862)

  • 1. 'It's not my greengrocer, it's someone from the medical profession': A qualitative study regarding acceptability of deceptive and open-label placebo prescribing in France.
    Druart L; Vauthrin O; Pinsault N; Locher C; Blease C
    Br J Health Psychol; 2023 May; 28(2):273-290. PubMed ID: 36086862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary care providers' use of and attitudes towards placebos: An exploratory focus group study with US physicians.
    Bernstein MH; Locher C; Stewart-Ferrer S; Buergler S; DesRoches CM; Dossett ML; Miller FG; Grose D; Blease CR
    Br J Health Psychol; 2020 Sep; 25(3):596-614. PubMed ID: 32472982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placebos in primary care? a nominal group study explicating UK GP and patient views of six theoretically plausible models of placebo practice.
    Ratnapalan M; Coghlan B; Tan M; Everitt H; Geraghty AWA; Little P; Lewith G; Bishop FL
    BMJ Open; 2020 Feb; 10(2):e032524. PubMed ID: 32075826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lay perspectives of the open-label placebo rationale: a qualitative study of participants in an experimental trial.
    Locher C; Buergler S; Frey Nascimento A; Kost L; Blease C; Gaab J
    BMJ Open; 2021 Aug; 11(8):e053346. PubMed ID: 34408060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating Pain With Open-Label Placebos: A Qualitative Study With Post-Surgical Pain Patients.
    Bernstein MH; Fuchs N; Rosenfield M; Weiss AP; Blease C; Locher C; Magill M; Rich J; Beaudoin FL
    J Pain; 2021 Nov; 22(11):1518-1529. PubMed ID: 34004348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Considering the case for an antidepressant drug trial involving temporary deception: a qualitative enquiry of potential participants.
    Dowrick CF; Hughes JG; Hiscock JJ; Wigglesworth M; Walley TJ
    BMC Health Serv Res; 2007 Apr; 7():64. PubMed ID: 17470280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deceptive but not open label placebos attenuate motion-induced nausea.
    Barnes K; Yu A; Josupeit J; Colagiuri B
    J Psychosom Res; 2019 Oct; 125():109808. PubMed ID: 31426018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of open-label and deceptive placebo analgesia in a healthy sample.
    Disley N; Kola-Palmer S; Retzler C
    J Psychosom Res; 2021 Jan; 140():110298. PubMed ID: 33227553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deceptive and Nondeceptive Placebos to Reduce Pain: An Experimental Study in Healthy Individuals.
    Kube T; Rief W; Vivell MB; Schäfer NL; Vermillion T; Körfer K; Glombiewski JA
    Clin J Pain; 2020 Feb; 36(2):68-79. PubMed ID: 31899746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient attitudes about the clinical use of placebo: qualitative perspectives from a telephone survey.
    Ortiz R; Chandros Hull S; Colloca L
    BMJ Open; 2016 Apr; 6(4):e011012. PubMed ID: 27044586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of pure and impure placebo interventions in primary care - a qualitative approach.
    Fent R; Rosemann T; Fässler M; Senn O; Huber CA
    BMC Fam Pract; 2011 Mar; 12():11. PubMed ID: 21435197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Open-Label Placebo Treatment: Outcome Expectations and General Acceptance in the Lay Population.
    Haas JW; Rief W; Doering BK
    Int J Behav Med; 2021 Aug; 28(4):444-454. PubMed ID: 33094438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When and why placebo-prescribing is acceptable and unacceptable: a focus group study of patients' views.
    Bishop FL; Aizlewood L; Adams AE
    PLoS One; 2014; 9(7):e101822. PubMed ID: 25006673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The patient's perspective of placebo use in daily practice: a qualitative study.
    Tandjung R; Tang H; Fässler M; Huber CA; Rosemann T; Fent R; Badertscher N
    Swiss Med Wkly; 2014 Feb; 144():w13899. PubMed ID: 24526325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placebo use in the UK: a qualitative study exploring GPs' views on placebo effects in clinical practice.
    Bishop FL; Howick J; Heneghan C; Stevens S; Hobbs FD; Lewith G
    Fam Pract; 2014 Jun; 31(3):357-63. PubMed ID: 24736295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deceptive and open-label placebo effects in experimentally induced guilt: a randomized controlled trial in healthy subjects.
    Sezer D; Locher C; Gaab J
    Sci Rep; 2022 Dec; 12(1):21219. PubMed ID: 36481801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Open-label placebo response - Does optimism matter? A secondary-analysis of a randomized controlled trial.
    Locher C; Frey Nascimento A; Kossowsky J; Meyer A; Gaab J
    J Psychosom Res; 2019 Jan; 116():25-30. PubMed ID: 30654990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Training healthcare providers to respond to intimate partner violence against women.
    Kalra N; Hooker L; Reisenhofer S; Di Tanna GL; García-Moreno C
    Cochrane Database Syst Rev; 2021 May; 5(5):CD012423. PubMed ID: 34057734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are open-Label Placebos Ethical? Informed Consent and Ethical Equivocations.
    Blease C; Colloca L; Kaptchuk TJ
    Bioethics; 2016 Jul; 30(6):407-14. PubMed ID: 26840547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of positive information provision in open-label placebo effects.
    Barnes K; Babbage E; Barker J; Jain N; Faasse K
    Appl Psychol Health Well Being; 2023 Nov; 15(4):1406-1426. PubMed ID: 36932997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.